European Group - International Society for Apheresis

This is how TPE in the ICU looks like in 🇫🇷 prior to the #EXCHANGE-2 trial:
Epidemiology of Patients Treated With Plasma Exchange in a French Intensive Care Unit: An Observational Retrospective Study - Dupuis - Therapeutic Apheresis and Dialysis onlinelibrary.wiley.com/doi/full/10....

#seraph 100 to treat preeclampsia? Encouraging in vitro results by Amelie Gienapp et al.
onlinelibrary.wiley.com/doi/10.1111/...

Lipoprotein apheresis: Current overview and future outlook in clinical practice Lipoprotein apheresis (LA) remains a critical therapeutic approach for patients with severe lipid disorders, particularly those who fail to achieve ta…

Is there a future of lipoprotein apheresis? Read the latest paper by Prof. Schettler www.sciencedirect.com/science/arti...

The number of apheresis procedures to treat immune-mediated neurological diseases is on the rise Apheresis is used for the treatment of many different diseases, especially when conventional therapy lacks efficacy. There are however some diseases in which apheresis is accepted as first line therap...

New data from the World apheresis registry show an increase in #apheresis procedures for neurological diseases. While the total number of procedures did not increase #myasthenia gravis, #Guillain-Barré Syndrome, #multiple sclerosis, #CIDP and #NMOSD were on the rise.
www.trasci.com/article/S147...

Effect of therapeutic plasma exchange on amoxicillin, clindamycin, midazolam, and morphine pharmacokinetics in a critically ill child - Pediatric Nephrology We report a 15-year-old boy with severe septic shock and multiple organ failure, requiring intensive care and extracorporeal therapies, including veno-arterial extracorporeal membrane oxygenation, con...

How to dose drugs in a patient undergoing the extracorporeal triple whammy of #VA-ECMO #CVVHDF and #TPE? An anecdotal answer given in: link.springer.com/article/10.1...

#Apheresis Classics:
1541 citations so far for the seminal paper by Gail Rock et al. Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura | New England Journal of Medicine www.nejm.org/doi/full/10....

E-ISFA Regional 👍

Ken Yamaji (ISFA outgoing president) and Kriengsak Vareesangthip (congress president) hand over the flag of #ISFA to Rasheed Balogun (ISFA incoming president) and Amber Sanchez #ISFA congress president 2027. See you in San Diego.

Apheresis Equipment Market Projected to Reach USD 5 Billion by 2034, Growing at a CAGR of 7.00% The global apheresis equipment market was valued at USD 2.5 billion in 2024 and is expected to grow at a CAGR of 7.0% from 2025 to 2034. The market is driven by growing applications in therapeutic plasma exchange and blood component separation. Market Definition The Apheresis Equipment Market revolves around medical devices that perform extracorporeal blood separation to collect or remove specific components—such as plasma, platelets, red cells, leukocytes, or stem cells—returning the remaining blood back to the donor or patient. These systems utilize technologies like centrifugation and membrane filtration to support applications across blood donation centers, hospitals, and therapeutic settings—such as leukapheresis, plasmapheresis, stem cell harvesting, and therapeutic plasma exchange (TPE).

Apheresis Equipment Market Projected to Reach USD 5 Billion by 2034, Growing at a CAGR of 7.00%

The global apheresis equipment market was valued at USD 2.5 billion in 2024 and is expected to grow at a CAGR of 7.0% from 2025 to 2034. The market is driven by growing applications in therapeutic…

Starting day #3 of #ISFA 2025 with talks on rhabdomyolysis and ascites management.

Turn back the clock by #TPE or just another variation to the theme of midlife crisis?
Dobri Kiprov is showing that makers of the epigenetic clock are improved after #TPE. An expensive sip from the fountain of youth.

From bed (or in this case PET) to bench - cutting edge research on the effect of Lipoprotein(a) on cardiovascular pathophysiology by @kroonlab.bsky.social at #ISFA 2025.

#photopheresis nicely explained by Jennifer Schneiderman #ISFA 2025.

@tusharchopra.bsky.social summarizing the current status of #green #apheresis at #ISFA 2025. Everybody can implement small steps today!

Laying the foundation of what could be #TPE-MBD (therapeutic plasma exchange associated bone mineral disease) Amber P. Sanchez from @ucsdmedschool.bsky.social with new data on bone markers in #apheresis patients showing an impressive rise in #PTH.

Kornchanok Vareesangthip setting the stage to discuss findings in a national cohort of #apheresis patients.

One world different regulations - Daisuke Katagiri explaining techniques and reimbursement of apheresis in Japan.

Starting day #2 of #ISFA 2025 with a comparison of mTPE and cTPE by Mickael Beraud.

Comparing #TPE and #IA in the setting steroid refractory #MS - Johannes Drost.

Still unavailable in many industrialized countries - excellent overview of #immunoadsorption by Bernd Hohenstein.

Is there a future for lipid apheresis after the advent of pharmaceutical options to lower LDL-C and Lp(a)?
Provocative talk by Wolfgang Ramlow showing a remarkably low target attainment in a real life setting at #ISFA2025.

First #E-ISFA session is on lipids. Alfonso Ramunni “Is lipoprotein apheresis effective for coronary microvascular dysfunction in CHD patients?” at #ISFA 2025.

Chairing the two #E-ISFA sessions at #ISFA 2025 : Bernd Hohenstein & Wolfgang Ramlow.

#apheresis is team work and an art - not always as impressive as the opening ceremony of #ISFA 2025.

Ranistha Ratanarat giving a comprehensive overview of adsorptive technologies in #sepsis at #ISFA2025.

#sepsis remains one of the areas with the highest research activity on extracorporeal techniques but with the lowest number of positive RCTs. Excellent overview by Rasheed A. Balogun at #ISFA 2025.

#E-ISFA at #ISFA2025. An interesting program from #apheresis around the world is waiting.